 - Histologically confirmed diagnosis of iNHL Follicular lymphoma grade 1, 2, 3a; marginal zone lymphoma; small lymphocytic lymphoma or lymphoplasmacytic lymphoma after treatment with at least 1 or more prior rituximab-containing regimens. 